Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03104257 · ClinicalTrials.gov registry record
The Neural Correlates of Cannabis Use
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 162
- Enrollment target
NCT03104257 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 162 participants.
The verdict
NCT03104257 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 162 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the temporal course of recovery of CB1R availability and neural oscillations, in cannabis-dependent individuals at baseline, following 48 hour confirmed inpatient abstinence and after four weeks confirmed abstinence. This research will also examine associations between CB1R availability, neural oscillations and cognitive function.
Interventions
- DRUG [11-C]OMAR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2016-12 |
| Est. Completion | 2022-04-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03104257
The ClinicalTrials.gov registry entry for NCT03104257 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [11-C]OMAR is the first listed.
NCT03104257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03104257 about?
NCT03104257 is a clinical study titled "The Neural Correlates of Cannabis Use". The purpose of this research study is to determine the temporal course of recovery of CB1R availability and neural oscillations, in cannabis-dependent individuals at baseline, following 48 hour confirmed inpatient abstinence and after four weeks confirmed abstinence. This research will also examine ...
What is the current status of trial NCT03104257?
This trial is currently completed. The enrollment target is 162 participants. The study started on 2016-12. Estimated completion is 2022-04-27.
What interventions are being tested in trial NCT03104257?
The interventions under investigation include: [11-C]OMAR (DRUG).
Who is sponsoring clinical trial NCT03104257?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.